DECIPHERA PHARMACEUTICALS IN (DCPH)
US24344T1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to DCPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.68. This target is 71.54% above the current price.
DCPH was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DCPH.
In the previous month the buy percentage consensus was at a similar level.
DCPH was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-07 | Stifel | Maintains | Buy -> Buy |
| 2023-11-20 | JP Morgan | Reiterate | Neutral |
| 2023-10-31 | JonesTrading | Upgrade | Hold -> Buy |
| 2023-10-31 | Stifel | Maintains | Buy -> Buy |
| 2023-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-30 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-08-10 | Stifel | Upgrade | Hold -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | JMP Securities | Reiterate | Market Outperform |
| 2023-05-04 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-15 | JMP Securities | Reiterate | Market Outperform |
| 2023-02-08 | SVB Leerink | Reiterate | Outperform |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-07 | SVB Leerink | Maintains | Outperform |
| 2023-01-25 | Cowen & Co. | Maintains | Outperform |
| 2023-01-06 | JonesTrading | Upgrade | Sell -> Hold |
| 2023-01-04 | Guggenheim | Upgrade | Neutral -> Buy |
| 2023-01-04 | SVB Leerink | Maintains | Outperform |
| 2023-01-04 | Barclays | Maintains | Underweight |
| 2022-09-27 | Stifel | Maintains | Hold |
| 2022-09-12 | SVB Leerink | Maintains | Outperform |
| 2022-09-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-29 | Cowen & Co. | Initiate | Outperform |
| 2022-08-05 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2022-08-05 | SVB Leerink | Maintains | Outperform |
| 2022-08-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-28 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2021-12-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-08 | Stifel | Downgrade | Buy -> Hold |